Market Entry - Adjuvant Industry in Taiwan: Analysis of Growth, Trends and Progress (2020 - 2025)

About the Market

Increase in the prevalence of cancer, growing reimbursement initiatives by governments and insurance companies covering treatment for cancer, with growth in preference for the future prevention of cancer are some of the major drivers of this market. The overall market for oncology adjuvants is classified on the basis of applications such as chemotherapy, radiotherapy, immunotherapy etc. By diseases which are treated through adjuvants, this market is classified into breast cancer, colorectal cancer, sarcoma, Hodgkin’s lymphoma, glioblastoma, lung cancer, prostate cancer, and ovarian cancer. North America, followed by Europe dominates the global market for breast cancer treatment, due to increasing incidence of cancer cases and technological advancement in the region. Some of the market players in this industry include pharmaceutical manufacturers such as Amgen Inc., Eli Lilly Co., BMS, Biogen, AstraZeneca PLC, Sanofi, and Pfizer Inc.

About the Geography

Taiwan has a dynamic capitalist economy with a semi-presidential government. Its economy is now the 26th largest in the world, as per the International Monetary Fund’s (IMF) World Economic Outlook Database. The island enjoys strong growth sustained by the dynamism of the entire region, a population with high purchasing power, and an economy focused on technology.

Taiwan has one of the lowest fertility rates in the world, which tells us that the country is about to face labor shortages. To counter this, new regulations provide preferential tax incentives to foreign professionals employed in Taiwan, aimed at improving the overall environment for recruiting and attracting professionals from other countries. The regulations, which address a general shortage of professional talent, are expected to benefit up to 3,000 foreign professionals. Currently, a proposal has been made to establish "free economic demonstration zones" (FEDZ). The goal of building up these zones is to position Taiwan as Asia-Pacific’s Free Trade Center. The first phase of the plan has been launched in August 2013 and the draft Special Act for EPZ is awaiting ratification.

The major drawbacks for conducting business in Taiwan are the lack of direct communication with China, certain weakness in the protection of intellectual property, and a limited domestic market. Still, Taiwan ranks very high in the ease of doing business and its strategic geographical location serves as an entryway to China and the ASEAN markets. The modern infrastructure and excellent innovation capabilities make it an attractive destination for investors.

The Market Entry Series

Exploring global markets is now recognized as the shortest way to ensure high time to efficiency conversion, when trying to expand revenues past domestic markets, for firms both large and small. Our market entry series, priced suitably low contains the essentials of all the parameters (Refer: Table of Contents) you must be apprised of before you can have a well informed contemplation of a business opportunity in your choice of industry, in your choice of geography.